These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6879183)

  • 1. Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells.
    Steplewski Z; Lubeck MD; Koprowski H
    Science; 1983 Aug; 221(4613):865-7. PubMed ID: 6879183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.
    Steplewski Z; Sun LK; Shearman CW; Ghrayeb J; Daddona P; Koprowski H
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4852-6. PubMed ID: 3387441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monocyte-mediated cytotoxicity: the use of Ig-bearing hybridomas as target cells to detect trigger molecules on the monocyte cell surface.
    Graziano RF; Fanger MW
    J Immunol; 1987 Feb; 138(3):945-50. PubMed ID: 2949010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.
    Herlyn D; Koprowski H
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4761-5. PubMed ID: 6289317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.
    Huls G; Heijnen IA; Cuomo E; van der Linden J; Boel E; van de Winkel JG; Logtenberg T
    Cancer Res; 1999 Nov; 59(22):5778-84. PubMed ID: 10582699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
    Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
    J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors.
    Smith KG; Austyn JM; Hariri G; Beverley PC; Morris PJ
    Eur J Immunol; 1986 May; 16(5):478-86. PubMed ID: 2938973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis: macrophages as effector cells for human tumor destruction mediated by monoclonal antibody.
    Steplewski Z; Herlyn D; Maul G; Koprowski H
    Hybridoma; 1983; 2(1):1-5. PubMed ID: 6678794
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo.
    Li B; Xu L; Tao F; Xie K; Wu Z; Li Y; Li J; Chen K; Pi C; Mendelsohn A; Larrick JW; Gu H; Fang J
    Oncotarget; 2017 Jun; 8(24):39356-39366. PubMed ID: 28454118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bispecific antibody targeting of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 to human macrophages through the Fc IgG receptor I mediates neutralizing effects in HIV-1 infection.
    Mabondzo A; Aussage P; Bartholeyns J; Le Naour R; Raoul H; Romet-Lemonne JL; Dormont D
    J Infect Dis; 1992 Jul; 166(1):93-9. PubMed ID: 1535093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine immunoglobulin G anti-CD4 monoclonal antibodies bind to primary human monocytes and macrophages through Fc receptors as well as authentic CD4.
    Teppler H; Lee SH; Rieber EP; Gordon S
    AIDS; 1990 Jul; 4(7):627-32. PubMed ID: 2397055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Destructive interactions between murine macrophages, tumor cells, and antibodies of the IgG2a isotype.
    Johnson WJ; Steplewski Z; Koprowski H; Adams DO
    Adv Exp Med Biol; 1985; 184():75-80. PubMed ID: 2931004
    [No Abstract]   [Full Text] [Related]  

  • 13. Phagocytosis by mouse peritoneal macrophages plated on monoclonal antibody-coated immune complex-substrates: effects of complexes of different IgG subclasses on Fc receptor functions.
    Sung SS
    J Immunol; 1985 Sep; 135(3):1981-6. PubMed ID: 4020136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor necrosis factor-α antibodies induce regulatory macrophages in an Fc region-dependent manner.
    Vos AC; Wildenberg ME; Duijvestein M; Verhaar AP; van den Brink GR; Hommes DW
    Gastroenterology; 2011 Jan; 140(1):221-30. PubMed ID: 20955706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of Fc receptors of lymphocytes, macrophages and other mammalian cells in immune processes].
    Liampert IM
    Usp Sovrem Biol; 1982; 94(1):67-82. PubMed ID: 6753399
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoclonal antibodies against T cell differentiation antigens initiate stimulation of monocyte/macrophage oxidative metabolism.
    Descamps-Latscha B; Golub RM; Nguyen AT; Feuillet-Fieux MN
    J Immunol; 1983 Nov; 131(5):2500-7. PubMed ID: 6195264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophages.
    Lohse S; Brunke C; Derer S; Peipp M; Boross P; Kellner C; Beyer T; Dechant M; van der Winkel JG; Leusen JH; Valerius T
    J Biol Chem; 2012 Jul; 287(30):25139-50. PubMed ID: 22679018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.
    Schulz G; Bumol TF; Reisfeld RA
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5407-11. PubMed ID: 6577434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32).
    Ball ED; Guyre PM; Mills L; Fisher J; Dinces NB; Fanger MW
    J Hematother; 1992; 1(1):85-94. PubMed ID: 1365020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.